News
Nonsteroidal MRAs Reduce Kidney, Cardiovascular Risks
The systematic review and meta-analysis included a broad range of patients with and without chronic kidney disease.
Your search for ESKD returned 11 results
News
Comparable Adverse Effects Seen for HIF-PHIs and ESAs
Investigators report results from a systematic review and meta-analysis of data from 23 randomized controlled trials involving 15,144 patients with anemia of CKD.
News
Uric Acid-Lowering Therapy May Increase Risk for CKD
Study findings do not support initiation of uric acid-lowering therapy to prevent CKD.
News
Preferential Use of Lactated Ringer vs Saline May Reduce Adverse Kidney Events
This study raises important questions about the choice between lactated Ringer and saline.
News
Underuse of Diabetic Kidney Disease Therapies Reported
Study findings highlight an "unmet need" for newer therapies.
News
SGLT2 Inhibitors Underprescribed for Chronic Kidney Disease
Affordability of SGLT2i may contribute to the low prescription rate in CKD.
News
Finerenone Provides CV, Renal Benefits in Diabetes Across CKD Spectrum
In FIDELITY, investigators pooled data from more than 13,000 patients from the FIDELIO-DKD and FIGARO-DKD trials.
News
Acute Kidney Injury in Severe COVID-19 Cases Predicts Higher Death, Cardiovascular Risks
A study found no significant increased risks for death or major adverse cardiac events among infected patients with established chronic kidney disease or end-stage kidney disease.
News
Psoriasis Treatment May Decrease Infection, Death Risk in End-Stage Kidney Disease
Psoriasis may be another risk factor for infectious complications in patients receiving dialysis, according to investigators.
News
Dapagliflozin Reduces Risk for Kidney Events in IgA Nephropathy
In patients with IgA nephropathy, dapagliflozin significantly reduced the risk of CKD progression when added to ACEi/ARB therapy.
